Management of Hypertensive Emergencies with Labetalol and Hydralazine

Introduction to Hypertensive Emergency Management

The European Society of Cardiology recommends labetalol as first-line therapy for managing acute hypertension due to its predictable responses, shorter duration of action, and combined alpha and beta-adrenergic blockade 1, 2

Labetalol has a more predictable response and shorter duration of action (3-6 hours) compared to hydralazine, making it a preferred agent for acute blood pressure control 3
The American College of Cardiology recommends labetalol as first-line therapy in multiple hypertensive emergency scenarios, including malignant hypertension, hypertensive encephalopathy, and acute ischemic stroke with elevated blood pressure 1, 2

Hydralazine has an unpredictable response and prolonged duration of action, making it less desirable as a first-line agent for acute treatment in most patients, according to the American Heart Association 3
Hydralazine causes reflex tachycardia, which can be problematic in patients with coronary artery disease or aortic dissection, as noted by the American College of Cardiology 3

In acute aortic dissection, labetalol is specifically recommended due to its combined alpha/beta blocking effects, as suggested by the American Heart Association 3
In acute coronary syndromes, labetalol is preferred to prevent reflex tachycardia, according to the European Society of Cardiology 2, 3
In acute ischemic stroke with blood pressure >220/120 mmHg, labetalol is recommended as first-line therapy, as recommended by the European Society of Cardiology 1, 2

In preeclampsia/eclampsia, hydralazine may be preferred along with labetalol and nicardipine, as suggested by the American College of Obstetricians and Gynecologists 3, 5
Labetalol is contraindicated in patients with severe bradycardia, heart block, or decompensated heart failure, as noted by the American Heart Association 3